Pfizer is a research-based, global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Co. collaborates with healthcare providers, governments and local communities to support and expand access to healthcare around the world. Co. provides vaccines across various ages (infants, adolescents and adults) in pneumococcal disease, meningococcal disease, tick-borne encephalitis and novel coronavirus disease of 2019 (COVID-19). Key products include: Comirnaty/BNT162b2, the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba. When considering the Pfizer Inc stock dividend history, we have taken known splits into account, such that the PFE dividend history is presented on a split-adjusted ("apples to apples") basis. Pfizer Inc dividend history is presented both in graphical/chart form, and as a PFE dividend history data table along the right-hand column.
|
PFE Stock Dividend HistoryThe PFE dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable PFE historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the PFE dividend history record. Also see the PFE stock dividend history data table along the right-hand column below. |
|
PFE Next Dividend Date » (Projection based upon history) PFE Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.81 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: PFE Forecast Based on data provided by Zacks Investment Research via Quandl.com |
Projection: PFE Next Dividend Date Chart: PFE Chart - 5Yr Dividend Yield |